Member Info for hasiba

RR…” Basic contract law - there has to be an offer, an acceptance and a consideration) ”
Can you please post a link ?
You are digging a bigger hole for yourself!!
Keep on going with your mates.. wouldn’t help I can assure you.
GL

Nil significant ..market mute reaction tells you so.Trading volumes is confirming this and shows lack of interest too..
Market radar is very strong and well ahead of us ..
Waffle and more of the same ..imo
We are investing in hopes and expectations and the market wants far more to believing us..more punters are waiting too..
Business as usual ..
The focus on RM and M/A in the short term…big Pharmas are watching too..for early datas.
Not deramping but reality checks.
Holding strong..
GL

Konar…I can see you are trying to help your Pal RR but honestly you would do more harm than good to him and yourself…by diverting the main issue.
I never posted sclp didn’t sell any product…or did I!
I posted facts that sclp never received any “OFFERS” to any of its products…
Investors should be aware of the big difference….it doesn’t matter of what we agree on or not..
We are putting big cash investments here.as PIs…
If it makes you feel better …”Sclp never received any offer to any of its products since it was listed on AIM(11 years ago) ..” how about this? Do we have agreement on this…but if sclp had received any offer..please let’s know…

Ok I tell you the difference between selling a product and receiving offer…as you seem to misunderstand the big difference..

Selling a product is basically persuading other party to buy it from you at your desperate needs usually cash. Not good

Receiving offers as your product is desired and be made profitable by other party and offers you big premium which push the SP much higher…and sclp never received such offers…very good.

Big difference..

Cont…
I am waiting RuckRover….
No offers were made to sclp…in my own research.
Maybe you are not able to differentiate between selling a product and receiving an offer either!
Come on…give us more of your investment acumen..!

RR…
Thank you for your unpleasantness!
Tell us what offers sclp had received to educate us “newbie”! As you come across with an attitude of overinflated self esteem…lol

…” I guess it depends if it was a formal offer. I’m not sure about the rules to be honest!”

Any information which affect SP movement must be declared as RNS to the public and shareholders alike.

Informal discussions are different…
Remember we had no offer declared on any product in 25 years but our products are currently optimised and refined and corporate actions will be forthcoming imo…as there is a defined strategy,plans and specifically important healthcare specialists funds are behind us.

We just need different views and more contrarians to balance this rampy bb by many posters here so we can all benefit.
GL

RP…
LD .. attempts to apply academic innovation to the challenge of discovering new drugs to address the urgently unmet needs are admirable ..
I am investing here not necessary because of her being here or her innovative thoughts and processes but when add all this to the heavy financial commitment of RM then the investing case was created with lesser risk and more rewards in the near horizon by corporate actions to monetise their products,generate revenues and profits to strengthen their financials and keep on progressing at speed.
Without the above plans sclp is back to its old days of raising funds with tiny progresses with failing objectives..
IMO…with due respects to lth investors here..sclp was not investable ..in past old days.
Now we are investing in the new direction and strategy mainly led by RM…in comparison to their past with no clear strategy or plans on how to commercialise their products.

Science without commercialisation is not what I invest in…what’s the point of having any assets in any company you are not able to sell ! Or make revenues and profits..

GF…
I wouldn’t chastise you and respect your opinion but really we must balance the far more rampings than deserved . We as shareholders own nearly half of the company and must express different views rather than allow the management taking us for granted..
Remind me of one single BoD bought any share herein the last 12 months apart from MDigg trading now and again for small profits!
And if there was an offer then surely that would have been RNSed?

Why would you advise investors to sell if they are having different views from yours?! and presume they are unhappy!
GL

roses….” Lol, one day does not make a market.
Neither does two.
You seem to be very, very impatient since you sold.”

Talk is cheap!
Probably I hold multiples of what you do…
Go and fill your boots in the next two days then!

GL

Let’s see tomorrow how many here will put their money where their mouth is!
GL

Nothing we didn’t know or expected….
That’s why sp has not reacted but in fact ended slightly lower…market mute response!
Sorry not convinced ..
Anyhow..many thanks Bb for posting..
GL holders

Zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz….zzzzzzzzzzz

Zzzzzzzzzzz….

Don’t expect any relevant information that is not already reflected in sp by the company RNSs and CEO latest interviews.
Market perception is starkly different from some over excited PIs here..
SP following previous AGM meetings in the last few years had in fact declined!
GL

RP…” It's taken 2 years to recruit the first patient and they are planning on 44 patients
Let's hope things speed up since 88 years is a long wait to complete recruitment :-)” lol

Non- inferiority trial will probably be completed earlier…H1 2022 imo
Holding very long and strong!

Been here for a while and definitely seems the old PMO holders started to reap the benefits of their patience..
Holding strong and long.
GL

Keep holding or add more..imo
Heading back towards 30p soon
Glad I have added last week
GL

Added 100k shares at 14.825p
GL holders

GGP is classic on technicals Lassonde curve..
Time of many investors giving up and sell at this stage of the curve but for experienced/patient investors the adding or entering at this stage of the GGP is perfect..
As always dyor

TF….
“We are delighted to have started our SCIB1 phase 2 trial in the UK as we believe that SCIB1 administration in combination with an immune checkpoint inhibitor such as pembrolizumab has the potential to offer (greater efficacy )than when either agent is used alone,” said chief executive officer Lindy Durrant.""

Which part of this statement you didn’t understand…..the CEO stated …”TO OFFER GREATER EFFICACY “..meaning greater health and desired benefits to patients..

And who told you non- inferiority trials is limited to 30% ..! Also It can achieve much higher than 30% with other additional desired health benefits to patients..dyor
Please research what EFFICACY means too in drugs trials..